MKI67 and prostate carcinoma: Used for analysis were Ki67 positivity data from a cohort of PDEs obtained from 122 prostate cancer patients that were cultured in the presence of vehicle control (DMSO) or clinically used prostate cancer drug enzalutamide (10 μM), as previously described [37].